Evicenter
P&T meetings

RP-A501 (AAV9.LAMP2B)

Danon disease

Regulatory submission
BLA planned for late 2028
Last updated
300 sources

Product information and disease descriptionPlace of product in therapyDisease description

Long-term morbidity

9 evidence topics · 32 sources

Implanted cardiac devices and catheter ablation: frequency in cohorts
After heart transplantation: skeletal muscle weakness and other extracardiac events
Late outcomes in females